AI to improve heart ultrasound scans after chemotherapy
Part of Heart & circulation, Injuries & trauma clinical trials.
This study uses artificial intelligence to help doctors get clearer heart ultrasound images in people who have had chemotherapy that can affect the heart. If you already get these heart scans, the AI may help make them more accurate and faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have had chemotherapy that is known to possibly affect the heart (cardiotoxic chemotherapy).
- You normally get a heart ultrasound (echocardiogram) to monitor your heart during or after treatment.
- You do not have a pacemaker or defibrillator implanted in your chest.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to analyze heart ultrasounds from people hospitalized with heart failure. It aims to see if AI can help doctors better measure heart function and guide treatment.
This study uses artificial intelligence to look at echocardiograms (ultrasounds of the heart) from heart transplant patients. It aims to see if AI can help predict rejection or other problems, potentially reducing the need for biopsies.
This trial tests whether using an artificial-intelligence (AI) tool during a heart ultrasound can help guide care for people at risk for heart problems. You might benefit if you have symptoms with exercise or heart risk factors, but you do not already have known heart failure or major heart disease.
This study uses artificial intelligence to analyze heart ultrasound images from patients hospitalized with serious heart conditions. It aims to improve how doctors predict patient outcomes.
This trial compares artificial intelligence (AI) to a trained sonographer for analyzing heart ultrasound images in people with heart failure. The goal is to see if AI can provide accurate reports faster or more consistently.
This study tests an artificial intelligence program designed to automatically take measurements from standard heart ultrasound images. It aims to see if the AI works as well as expert doctors.
Hear when a new Cardiotoxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.